Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXT0BN
|
||||
Drug Name |
(R)-5-(4-Benzoyl-piperidin-1-yl)-5-oxo-4-(3-m-tolyl-ureido)-pentanoic acid benzyl ester
|
||||
Synonyms |
CHEMBL103276
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C32H35N3O5
|
||||
Canonical SMILES |
Cc1cccc(NC(=O)N[C@H](CCC(=O)OCc2ccccc2)C(=O)N3CCC(CC3)C(=O)c4ccccc4)c1
|
||||
InChI |
InChI=1S/C32H35N3O5/c1-23-9-8-14-27(21-23)33-32(39)34-28(15-16-29(36)40-22-24-10-4-2-5-11-24)31(38)35-19-17-26(18-20-35)30(37)25-12-6-3-7-13-25/h2-14,21,26,28H,15-20,22H2,1H3,(H2,33,34,39)/t28-/m1/s1
|
||||
InChIKey |
DUPJRHKBDSHZPG-MUUNZHRXSA-N
|
||||
Target and Pathway | |||||
Target(s) | Gastrin/cholecystokinin type B receptor | Target Info | [1587926] | ||
Cholecystokinin receptor type A | Target Info | [1587926] | |||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.